World Backup Day 2024
World News: Protect data in time for World Backup Day NEW YORK–(BUSINESS WIRE)–#Apple–B&H is pleased to announce that March 31, 2024, is World... Read more.
SpyCloud Report: 61% of Data Breaches in 2023 Were Malware Related
Average identity has 1 in 5 chance of already being victim of infostealer malware infection AUSTIN, Texas–(BUSINESS WIRE)–SpyCloud, the leader in Cybercrime... Read more.
Teva UK and Closed Loop Medicine Announce Strategic Partnership to Advance Development of Personalised Medicines
CASTLEFORD, England & LONDON–(BUSINESS WIRE)–Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development... Read more.
Inversion6 Welcomes Tom Siu as New Chief Information Security Officer
An accomplished security executive with 30 years of varied leadership experience in multiple sectors joins Cleveland cybersecurity company’s fractional CISO... Read more.
Align Capital Partners Establishes Specialty Tax Platform
CLEVELAND & DALLAS–(BUSINESS WIRE)–Align Capital Partners (“ACP”) is pleased to announce the formation of a specialty tax consulting... Read more.
McDonald’s® USA and Krispy Kreme® Announce Expanded National Partnership
Krispy Kreme to provide fresh doughnuts daily at McDonald’s restaurants nationwide; Phased rollout will begin in 2H 2024 with nationwide availability expected... Read more.
Everest Business Funding Recaps the 2024 Funders Forum and Broker’s Expo
With over 700 guests in attendance, the Funders Forum and Broker’s Expo was at its best in 2024. Everest Business Funding was a Diamond Sponsor this year,... Read more.
Cyware Earns Premier 5-Star Rating in 2024 CRN® Partner Program Guide for Second Year Running
NEW YORK–(BUSINESS WIRE)–#5StarAward–Cyware, the leader in threat intelligence management, security collaboration, and orchestrated response, has... Read more.
Atamyo Therapeutics Obtains Regulatory Authorization in Europe to Initiate a Clinical Trial for ATA-200, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2C/R5
Atamyo has received approval to initiate a clinical trial of ATA-200 gene therapy in France and Italy ATA-200 is a single-injection gene therapy aimed to treat LGMD2C/R5... Read more.
Ubiquigent and Debiopharm Enter Agreement to Support USP1 Inhibitor Programme for Debio 0432
Project will be a demonstration of how Ubiquigent’s DUB-centric platform can support the development of DUB inhibitors all the way from discovery through... Read more.